ATTENZIONE!!!SI STA NAVIGANDO UNA VECCHIA VERSIONE DEL SITO
CLICCARE QUI PER LA VERSIONE ATTUALE DEL BOLLETTINO D'ATENEO
Comunicazioni dal rettore

PARTNER SEARCH HEALTH-PT-LCP-6


 
 
01 dicembre 2017

PARTNER SEARCH HEALTH-PT-LCP-6

Richiesta di un'azienda israeliana alla ricerca di partner da includere in un loro progetto da presentare nel programma COOPERATION tematica SALUTE.
Per maggiori informazioni sulla Ricerca Partner e per conoscere i contatti del proponente, consultare il seguente indirizzo web.http://www.apre.it/formaAssist/scheda.asp?id=1045

---------------------------------------------------
------- PARTNER SEARCH HEALTH-PT-LCP-6 --------
---------------------------------------------------
<Reference n.: HEALTH-PT-LCP-6>
<Deadline: 01/10/2008>
<Programme: >
<Project Title: Development of mucosal and topical vaccines for poverty related diseases>
<Financial Scheme: Progetti in collaborazione - Large>
<Description: Transdermal/mucosal drug delivery is a powerful method for massive treatment and/or vaccination against various diseases. This method is especially useful in children and in Developing Countries. The proposed project aims at identifying new potential immunogens and adjuvants and will take advantage of the newest available genetic and immunological information to design and develop vaccine candidates against HIV, malaria and/or TB for local application. A network of research partners from EU and HIV-, malaria- and TB-endemic countries will be built.

Goal
The ultimate goal of the proposed research is to design and develop vaccine candidates against HIV, malaria and/or TB for mucosal and/or trans-cutaneous application
Proposal to
- Identify new immunogens and adjuvants with a potential to elicit a prophylactic or therapeutic immune response.
- Develop potent transdermal/mucosal delivery vaccines for local application

<Organisation Type: Impresa>
<Partner Sought: Expertise sought for:
- Partners from HIV, malaria and TB-endemic countries
- Immunology and clinician,experts in HIV,malaria and TB
- companies specializing in the development of vaccines
- companies specializing in transdermal and/or mucosal delivery systems